Institutional investors purchased a net $12.6 million shares of DNDN during the quarter ended March 2014 and now own 38.20% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 9.8 Thousand shares of Dendreon Corp
SYZ ASSET MANAGEMENT SA Bought 12.00 shares of Dendreon Corp
EDGE WEALTH MANAGEMENT LLC Sold 200.00 shares of Dendreon Corp